KATHERINE NORRICK: Open Payments
NPI 1891249009 · FESTUS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,170 in 65 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $377 · 2025 $1,170
Food & beverage: $1,170
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $356 |
| AstraZeneca Pharmaceuticals LP | 9 | $154 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $83 |
| Sumitomo Pharma America, Inc. | 3 | $82 |
| Novo Nordisk Inc | 4 | $70 |
| Exact Sciences Corporation | 3 | $62 |
| PFIZER INC. | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $55 |
| Medtronic, Inc. | 2 | $40 |
| Amgen Inc. | 2 | $37 |
Products named: VRAYLAR, QULIPTA, CAPLYTA, GEMTESA, AIRSUPRA, UBRELVY, XIFAXAN, BREZTRI.
Industry payments across MO — which companies pay providers there.
